Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Gross Margin (2020 - 2025)

Macrogenics (MGNX) has disclosed Gross Margin for 6 consecutive years, with 100.0% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 58.0% to 100.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 100.0% through Dec 2025, up 52.0% year-over-year, with the annual reading at 100.0% for FY2025, 56.0% up from the prior year.
  • Gross Margin for Q4 2025 was 100.0% at Macrogenics, roughly flat from 100.0% in the prior quarter.
  • The five-year high for Gross Margin was 100.0% in Q1 2025, with the low at 89.37% in Q3 2021.
  • Average Gross Margin over 5 years is 98.01%, with a median of 99.48% recorded in 2023.
  • The sharpest move saw Gross Margin tumbled -1063bps in 2021, then skyrocketed 654bps in 2022.
  • Over 5 years, Gross Margin stood at 93.31% in 2021, then rose by 7bps to 99.84% in 2022, then decreased by -1bps to 98.48% in 2023, then grew by 1bps to 99.42% in 2024, then increased by 1bps to 100.0% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 100.0%, 100.0%, and 100.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.